At Moffitt Cancer Center, we strive to be the leader in understanding the complexity of cancer and applying these insights to contribute to the prevention and cure of cancer. Our diverse team of over 9,000 are dedicated to serving our patients and creating a workspace where every individual is recognized and appreciated. For this reason, Moffitt has been recognized on the 2023 Forbes list of America’s Best Large Employers and America’s Best Employers for Women, Computerworld magazine’s list of 100 Best Places to Work in Information Technology, DiversityInc Top Hospitals & Health Systems and continually named one of the Tampa Bay Time’s Top Workplace. Additionally, Moffitt is proud to have earned the prestigious Magnet® designation in recognition of its nursing excellence. Moffitt is a National Cancer Institute-designated Comprehensive Cancer Center based in Florida, and the leading cancer hospital in both Florida and the Southeast. We are a top 10 nationally ranked cancer center by Newsweek and have been nationally ranked by U.S. News & World Report since 1999.
Working at Moffitt is both a career and a mission: to contribute to the prevention and cure of cancer. Join our committed team and help shape the future we envision.

Summary

Candidate will oversee compounding of hazardous and non-hazardous preparations in accordance with most current USP guidelines, utilizing the standards of sterile admixture, including appropriate hazardous waste disposal and high-risk medication double check system.

 

Responsibilities:

Ensures safe and effective dispensing, order validation and processing of chemotherapy and non-chemotherapy orders. Adheres to the institutional high-risk standards, guidelines and policies for chemotherapy/biotherapy, handling and dispensing. Checks all technician activities for proper selection, labeling, preparation, and documentation of drug dispensing.

 

Credentials and Qualifications:

Minimum of Bachelor's degree in Pharmacy required. Licensed as a Pharmacist in the state of Florida required. Either three (3) years of progressive Institutional Oncology Pharmaceutical Experience or Advanced Pharmacy Practice Residency (PG-Yl).